Adherence
Using GLP-1 receptor agonists for weight loss results in higher social stigma and lower willingness to affiliate compared to losing weight through diet and exercise, and is stigmatized even more than remaining at a higher weight without attempting weight loss.
If you use GLP-1s for weight loss, be aware that you may face significant social judgment, potentially more than if you stayed at your current weight. This stigma stems from perceptions that medication is an 'easy shortcut' compared to diet and exercise. This social penalty can undermine the psychological benefits of weight loss and may discourage continued treatment. It is important to seek support and understand that this stigma is a social bias, not a reflection of your health efforts.
In Study 1, we found that participants evaluated an individual who lost weight with a GLP-1 more harshly than an individual who lost weight via diet and exercise... Moreover, they evaluated an individual who lost weight with a GLP-1 even more harshly... than a higher-weight individual who had not attempted weight loss.
Why this rating
Randomized controlled experiments with large sample sizes (N=607, N=706) and pre-registered hypotheses.
Source
An experimental investigation of the stigmatization of weight loss and regain from GLP-1 receptor agonist use and cessation
Erin C. Standen et al. · International Journal of Obesity · 2026
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →